Dogs have lived alongside humans for thousands of years, but only recently have scientists begun to treat that partnership as a serious research asset. A growing body of work on the canine microbiota-gut-brain axis — the two-way communication network linking the gut, its microbes and the brain — suggests that dogs may be one of the most informative models available for studying social and affective disorders that also affect people.
The appeal is straightforward. Pet dogs share their owners’ homes, air, water, daily rhythms and even much of their microbial environment, yet their shorter lifespans mean that developmental and ageing processes unfold on a timescale researchers can actually observe. Add the fact that dogs are naturally social animals with rich emotional lives, and you have a model organism that laboratory rodents simply cannot replicate.
A Shared Microbial World
Studies of household dogs have repeatedly shown that a dog’s gut microbiome resembles that of its human family more closely than it resembles the microbiomes of unrelated dogs. Diet, environment and everyday contact all shape the microbial communities in the gut, and those communities in turn produce compounds — including short-chain fatty acids and neurotransmitter precursors — that can influence mood, stress responses and behaviour. Our latest health coverage regularly follows how this field is evolving.
For researchers interested in conditions such as anxiety, depression and social withdrawal, that shared environment matters enormously. When a dog and its owner respond to the same household stresses with similar microbial shifts, scientists gain a natural experiment that would be impossible to design deliberately in humans.
What the Canine Model Can Show
Recent research programmes are using dogs to explore how early-life microbial exposure shapes social development, how gut inflammation interacts with fear and aggression, and whether dietary or probiotic interventions can shift behaviour alongside microbiome composition. Because pet dogs receive veterinary care throughout their lives, researchers can pair behavioural testing with blood work, imaging and faecal sampling in ways that are both ethical and practical.
The work sits within a broader scientific conversation about the microbiome’s role in health, covered extensively by Nature’s microbiome research hub, and it is attracting funding precisely because the dog offers something rare: a socially complex mammal whose environment mirrors our own.
From Kennel to Clinic
Nobody is claiming that findings in dogs translate automatically to people. Canine and human physiology differ, and affective disorders in humans involve language, culture and cognition that no animal model captures. But the model has practical advantages for testing hypotheses quickly and safely — for example, screening whether a particular dietary intervention changes both microbial markers and measurable anxiety behaviours before anyone designs a human trial.
There are also direct benefits for dogs themselves. Behavioural problems are among the most common reasons pets are surrendered to shelters, and a better understanding of the gut-brain axis could lead to nutritional or medical support for anxious and reactive dogs. More related reading is available in our health section.
The Road Ahead
Citizen Science With a Lead On
One reason the canine programme is accelerating is that recruitment is unlike anything in human research. Owners volunteer in large numbers, share veterinary records, collect faecal samples at home and complete detailed behavioural diaries — a longitudinal dataset that would cost a fortune to assemble in people. Large owner-reported cohorts now track thousands of dogs across their whole lives, linking diet, environment, microbiome and behaviour year after year.
That scale is beginning to answer questions smaller studies could not: whether microbial patterns in puppyhood predict adult anxiety, how spaying, antibiotics and household chemicals perturb the system, and which interventions — dietary fibre, fermented foods, targeted probiotics — produce durable change rather than a temporary blip. Each answer refines the model for human psychiatry too, where gut-brain trials have historically struggled with exactly the variables dog cohorts capture naturally: real homes, real stress, real food and real relationships.
The field is still young, and its leaders are candid about what is missing: larger cohorts, standardised behavioural measures and longer follow-up. But the direction of travel is clear. As sequencing costs fall and pet-owner research panels grow, the dog is moving from the footnotes of neuroscience to the centre of one of its most promising research programmes — a fitting promotion for humanity’s oldest animal partner.
